Skip to content

CDMO growth to be unpredictable over next five years, states CPhI WW report

CPhI Worldwide has revealed the finding from part i of its fifth edition of the CPhI Annual Report, which show the trend towards the integration of pharmaceutical outsourcing continues but the rate of change remains unclear.

CDMO growth to be unpredictable over next five years, states CPhI WW report
Published: | 3 min read

CPhI Worldwide has revealed the finding from part i of its fifth edition of the CPhI Annual Report, which show the trend towards the integration of pharmaceutical outsourcing continues but the rate of change remains unclear.

report

This first part of the report features contributions from four industry experts — Gil Roth president, PBOA; Vivek Sharma, CEO at Piramal Pharma Solutions; BSV Prasad, sr vice president & head, Small Molecules Business, Biocon; and Sam Tadayon, executive director & Dr Minzhang Chen, CEO at STA Pharmaceutical.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information